Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Current Opinion in Hematology|September 22, 2015
Donor-derived CD19-targeted T cells in allogeneic transplantsChiara Francesca Magnani, Andrea Biondi, Ettore BiagiBulletin Du Cancer|June 13, 2003
[Gene therapy of childhood cancers: current status and perspectives]Raphaël Rousseau, Ettore Biagi, Catherine Bollard, et al.Oncoimmunology|August 2, 2014
CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?Sarah Tettamanti, Andrea Biondi, Ettore Biagi, et al.Journal of Biomedicine & Biotechnology|April 11, 2003
Gene Therapy for Pediatric Cancer: State of the Art and Future PerspectivesEttore Biagi, Catherine Bollard, Raphael Rousseau, et al.Blood|March 18, 2004
Antigen-induced regulatory T cellsStephane Vigouroux, Eric Yvon, Ettore Biagi, et al.Immunology Letters|October 1, 2013
Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectorsSarah Tettamanti, Chiara Francesca Magnani, Andrea Biondi, et al.Journal of Autoimmunity|August 28, 2017
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemiaAndrea Biondi, Chiara F Magnani, Sarah Tettamanti, et al.Current Pharmaceutical Design|June 26, 2012
From bone marrow transplantation to cellular therapies: possible therapeutic strategies in managing autoimmune disordersAndrea Taddio, Andrea Biondi, Elisa Piscianz, et al.Frontiers in Oncology|May 4, 2013
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectivesChiara F Magnani, Sarah Tettamanti, Francesca Maltese, et al.Experimental Hematology|August 31, 2006
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapyVirna Marin, Erica Dander, Ettore Biagi, et al.Pageof 6